These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 404249)

  • 21. Protection of mice against haemoprotozoan Babesia microti with Brucella abortus strain 19.
    Herod E; Clark IA; Allison AC
    Clin Exp Immunol; 1978 Mar; 31(3):518-23. PubMed ID: 95914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological role of Brucella abortus cell walls.
    FOSTER JW; RIBI E
    J Bacteriol; 1962 Aug; 84(2):258-68. PubMed ID: 13894243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial products as immunomodulating agents.
    Gialdroni-Grassi G; Grassi C
    Int Arch Allergy Appl Immunol; 1985; 76 Suppl 1():119-27. PubMed ID: 2858453
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 25. Ontogeny of Th1 memory responses against a Brucella abortus conjugate.
    Scharf O; Agranovich I; Lee K; Eller NL; Levy L; Inman J; Scott DE; Golding B
    Infect Immun; 2001 Sep; 69(9):5417-22. PubMed ID: 11500412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intracerebrally injected Corynebacterium parvum on the development and growth of metastatic brain tumor in mice.
    Kennedy JD; Sutton RC; Conley FK
    Neurosurgery; 1989 Nov; 25(5):709-14. PubMed ID: 2586725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
    Ghaffar A; Cullen RT
    J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection.
    Pardon P; Marly J
    Ann Immunol (Paris); 1976; 127(1):57-70. PubMed ID: 821385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization of Mice with Recombinant Brucella abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella abortus 544 Infection.
    Hop HT; Reyes AW; Simborio HL; Arayan LT; Min WG; Lee HJ; Lee JJ; Chang HH; Kim S
    J Microbiol Biotechnol; 2016 Jan; 26(1):190-6. PubMed ID: 26464379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of the antitumor action of Corynebacterium parvum by stress.
    Turney TH; Harmsen AG; Jarpe MA
    Physiol Behav; 1986; 37(4):555-8. PubMed ID: 3092254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mice immune responses to Brucella abortus heat shock proteins. Use of baculovirus recombinant-expressing whole insect cells, purified Brucella abortus recombinant proteins, and a vaccinia virus recombinant as immunogens.
    Bae JE; Schurig GG; Toth TE
    Vet Microbiol; 2002 Aug; 88(2):189-202. PubMed ID: 12135637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bovine monoclonal antibody specific for Brucella abortus lipopolysaccharide.
    Nielsen KH; Henning MD
    Vet Immunol Immunopathol; 1989 Jul; 21(3-4):363-72. PubMed ID: 2508298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.
    Jiménez de Bagüés MP; Elzer PH; Jones SM; Blasco JM; Enright FM; Schurig GG; Winter AJ
    Infect Immun; 1994 Nov; 62(11):4990-6. PubMed ID: 7927779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of mice against mouse hepatitis virus by Corynebacterium parvum.
    Schindler L; Streissle G; Kirchner H
    Infect Immun; 1981 Jun; 32(3):1128-31. PubMed ID: 6166566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitumor effect of Corynebacterium parvum].
    Mazurek C; Chalvet H; Biozzi G; Stiffel C
    Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions.
    Millman I; Scott AW; Halbherr T
    Cancer Res; 1977 Nov; 37(11):4150-5. PubMed ID: 409491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence.
    McQuiston JR; Vemulapalli R; Inzana TJ; Schurig GG; Sriranganathan N; Fritzinger D; Hadfield TL; Warren RA; Lindler LE; Snellings N; Hoover D; Halling SM; Boyle SM
    Infect Immun; 1999 Aug; 67(8):3830-5. PubMed ID: 10417145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308.
    Pasquali P; Rosanna A; Pistoia C; Petrucci P; Ciuchini F
    Infect Immun; 2003 May; 71(5):2326-30. PubMed ID: 12704101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
    Lichtenstein AK; Berek J; Kahle J; Zighelboim J
    Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement activity of anti-brucella sera in experimental Brucella abortus infection in mice.
    Forget A; Riendeau C
    Rev Can Biol; 1977 Sep; 36(3):239-43. PubMed ID: 412235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.